T. Rowe Price Investment Management, Inc. Procept Bio Robotics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,527,827 shares of PRCT stock, worth $59 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,527,827
Previous 1,415,403
7.94%
Holding current value
$59 Million
Previous $82.5 Million
6.72%
% of portfolio
0.06%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding PRCT
# of Institutions
290Shares Held
43.9MCall Options Held
266KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA5.25MShares$203 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$135 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$83.3 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$51 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$50.1 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.72B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...